Thomas Vogl

17PUBLICATIONS
61CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Major global burdens of diseaseAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Sep 02, 2026
HLA-II peptide-binding diversity shapes humoral immune responses and susceptibility to infections.

|Aug 27, 2026
CD19 CAR T cell therapy for treatment-refractory seropositive rheumatoid arthritis: a phase 1 trial.

|Jul 21, 2026
Deciphering the prodrome of inflammatory bowel disease up to 10 years before disease onset by massively parallel serology.

|Jul 02, 2025
Crohn's disease and ulcerative colitis exhibit prediagnostic antibody signatures with shared and divergent changes towards disease onset.

Arno R Bourgonje, Sergio Andreu-Sánchez, Ranko Gacesa

|Jun 02, 2025
Associations between HLA-II variation and antibody specificity are predicted by antigen properties.

|Sep 14, 2023
Use and outcome of TIPS in hospitalized patients in Germany: A Nationwide study (2007-2018).

Wenyi Gu, Yasmin Zeleke, Hannah Hortlik

Pageof 3

Frequent Collaborators

4 joint publications

Iris N Kalka

3 joint publications

Sigal Leviatan

3 joint publications

Adina Weinberger

3 joint publications

Eran Segal